Exicure Inc

詳細情報 Exicure Inc 企業名

Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.

企業情報

企業コードXCUR

会社名Exicure Inc

上場日May 09, 2018

最高経営責任者「CEO」Mr. Paul Kang

従業員数7

証券種類Ordinary Share

決算期末May 09

本社所在地2430 N. Halsted St.

都市CHICAGO

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号60614

電話番号18476731707

ウェブサイトhttps://www.exicuretx.com/

企業コードXCUR

上場日May 09, 2018

最高経営責任者「CEO」Mr. Paul Kang

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Sangjn Yeo

Director

--

Ms. Aejin Hwang

Director

--

Mr. Andy Yoo

President, Chief Executive Officer, Director

--

Mr. Joshua (Josh) Miller

Chief Accounting Officer

--

Mr. Seung Ik Baik

Chief Financial Officer, Company Secretary, Director

--

Mr. Dongho Lee

Independent Director

--

Mr. Paul Kang

Director

--

Mr. Dongho Lee

Independent Director

--

Mr. Paul Kang

Co-Chief Executive Officer

--

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Sangjn Yeo

Director

--

Ms. Aejin Hwang

Director

--

Mr. Andy Yoo

President, Chief Executive Officer, Director

--

Mr. Joshua (Josh) Miller

Chief Accounting Officer

--

Mr. Seung Ik Baik

Chief Financial Officer, Company Secretary, Director

--

Mr. Dongho Lee

Independent Director

--

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Fri, Aug 29

株主統計

種類

株主統計

比率

Hitron Systems Inc Employees

52.76%

DGP Co., Ltd.

7.80%

Sangsangin Investment & Securities Co. Ltd.

6.86%

Abingworth Management Limited

4.46%

CBI USA, Inc.

2.59%

他の

25.53%

株主統計

比率

Hitron Systems Inc Employees

52.76%

DGP Co., Ltd.

7.80%

Sangsangin Investment & Securities Co. Ltd.

6.86%

Abingworth Management Limited

4.46%

CBI USA, Inc.

2.59%

他の

25.53%

種類

株主統計

比率

Corporation

63.15%

Research Firm

6.87%

Venture Capital

4.46%

Investment Advisor

0.90%

Investment Advisor/Hedge Fund

0.31%

Hedge Fund

0.18%

Endowment Fund

0.17%

他の

23.97%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

39

5.19M

82.14%

+459.49K

2025Q1

39

5.11M

80.94%

+626.75K

2024Q4

39

2.19M

79.53%

+1.26M

2024Q3

38

1.16M

47.48%

+231.16K

2024Q2

41

935.92K

56.32%

-7.21K

2024Q1

63

954.65K

57.41%

-102.69K

2023Q4

69

1.01M

60.85%

-61.54K

2023Q3

83

1.06M

66.48%

-70.11K

2023Q2

96

1.06M

66.44%

-83.25K

2023Q1

130

1.14M

110.73%

-98.99K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Hitron Systems Inc Employees

3.33M

52.76%

--

Mar 12, 2025

DGP Co., Ltd.

849.22K

13.44%

+237.22K

+38.76%

Sep 12, 2024

Abingworth Management Limited

281.64K

4.46%

--

Mar 31, 2025

CBI USA, Inc.

163.66K

2.59%

--

Sep 12, 2024

The Vanguard Group, Inc.

19.03K

0.3%

+19.03K

--

Mar 31, 2025

UBS Financial Services, Inc.

566.00

0.01%

-1.07K

-65.49%

Mar 31, 2025

Geode Capital Management, L.L.C.

19.10K

0.3%

+6.45K

+51.03%

Mar 31, 2025

Northwestern University

10.43K

0.17%

--

Mar 31, 2025

詳細を見る

3.840USD

Exicure Inc

3.840

概要

企業名

金融

分析